IDH1 and glioblastoma: ATRX mutations occur in approximately 57% of secondary GBM; in GBM cells, ATRX mutations occur more frequently in IDH-mutant GBM than in wildtype (71% vs. exceptions) [15] and co-occur with IDH1 and TP53 mutations [34,35].